To identify myeloid cell populations driving tumor angiogenesis in HCC with a specific focus on the context of PD-1 inhibitor treatment, we performed integrative scRNA-seq analysis on 328 samples from 63 HCC patients who received anti-PD-1 therapy. Here, PDCD1 is linked to hepatocellular carcinoma.